Relivira
Underwear seller strips a number of marketing claims after a TINA.org inquiry.
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
Tesla Needs to Pull the Plug on Its Deceptive Made in USA Claims
TINA.org notifies electric vehicle maker for second time in three years.
Ford, Stellantis run ad campaigns touting their American heritage to influence Trump
Jamie L. LaReau, Detroit Free Press
Wood-N-Tap
Getting hangry over a hidden delivery fee.
CATrends: Deceptive ‘Plant-Based’ Claims
A deceptive marketing trend takes root.